ELEVATE-TIMI 56 assessed whether higher as compared with lower maintenance doses of clopidogrel can adequately improve the degree of platelet inhibition in carriers of a reduced-function CYP2C19 allele. MAIN RESULTS: Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease JAMA. 2011 Nov 23;306(20):2221-8. PRESENTATIONS TIMI 56 … Continue reading ELEVATE-TIMI 56